Clinical Trial Results
Showing:
All studies
[change]
Condition: Cancer
Location: Lebanon, New Hampshire
25 trials found
New Search
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
RECRUITING
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
RECRUITING
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
RECRUITING
Healthy Homes Study
RECRUITING
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
RECRUITING
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
RECRUITING
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
RECRUITING
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RECRUITING
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RECRUITING
Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
RECRUITING
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
RECRUITING
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RECRUITING
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RECRUITING
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
RECRUITING
Immune Profiling for Cancer Immunotherapy Response
RECRUITING
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RECRUITING
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
RECRUITING
Telmisartan in Prostate Cancer
RECRUITING
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
RECRUITING
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
RECRUITING
TRAIL Study: Feasibility and Pilot
RECRUITING
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RECRUITING